InvestorsHub Logo
Followers 0
Posts 331
Boards Moderated 0
Alias Born 06/10/2004

Re: Cytotekk post# 1849

Monday, 07/03/2006 7:25:27 PM

Monday, July 03, 2006 7:25:27 PM

Post# of 30974
The numbers support Loss_slayer

I posted this on RB, but I think it is worth repeating here because of the points made by Loss. I fully understand Loss' frustration with this company because the numbers reported have been pathetic. All the personal attacks in the world cannot change the SEC filings.

I honestly do not see how anyone could read the last quarterly report and be optimistic about this company. The numbers are not good.

Revenue: $4,800
Expenses: $24,900
Loss: ($20,100)

Even if revenue increases 4 fold as projected, the numbers still paint a bleak picture:

Revenue: $19,900
Expenses: $24,900
Loss: ($5,700)

To be optimistic, what if revenue increases 8 fold over the next few years?

Revenue: $39,800
Expenses: $24,900
Profit: $14,900
Profit/year: $60 k
Shares: 66 million
Price: $.024
Market cap: $1.6 million
P/E: 27

A P/E of 27 is NOT a bargain by any means, especially when you are looking out 3-4 years with a best case scenario.

In my opinion, the royalties this company is receiving are very disappointing. I think Ball misled investors in that he did not provide any guidance whatsoever on the royalty structure until AFTER it was painfully obvious that the royalties were extremely low. I do not see how this company deserves a market cap of $1.6 million, and I do not see why it even publicly trades. This is not really a company; it is just a consultant earning some fees.